Holds a J.D. from Santa Clara University and a master’s degree in materials chemistry from Nankai University, is admitted to the California Bar, is qualified as a patent agent in both China and the United States, and previously worked in materials chemistry R&D. She focuses on overseas patent filing and portfolio strategy in biopharma, semiconductor materials and chemicals, is experienced in US trademark disputes and patent invalidation proceedings, and takes part in bilingual negotiation of cross-border technology cooperation agreements.
PCT international phase or direct national filing, including document localisation and coordination with foreign agents; official fees are billed separately.
One application designating multiple countries through the Madrid System, including the basic application and transmission by the International Bureau; national fees are paid separately.
Filings in the United States, the European Union, Japan, Korea and Hong Kong, China; Macao, China and Taiwan, China, with local agent coordination.
Review of development, commissioning, cooperation and licence contracts, with a written opinion, a revised contract and a risk checklist.
Restructured the claim hierarchy to match the examination practice of the target countries and organised experimental data to support the inventiveness argument.
Reviewed evidence of use and prior rights under US trademark practice, then selected and pursued opposition or cancellation proceedings.
Built a layered portfolio across materials, processes and devices, filling right gaps in the target markets and setting a filing schedule.
Designed the clauses on ownership of results, ownership of subsequent improvements and dispute resolution, and took part in bilingual negotiation.
Leave your details and Chen Qing or the team will get back to you within one business day.
WeCom
Scan to add our consultant; we respond on business days.
